FDA · 药品动态·· 2026-09-30AI 评分20
Reed Seward 谈 FDA 加速批准通道为何既是突破也是隐患
Reed Seward on Why the FDA's Accelerated Approval Pathway Is Both a Breakthrough and a Liability - healthtechzone.com
AI 导读
Reed Seward 就 FDA 加速批准通道发表观点,认为该通道既是突破也是隐患。文章围绕这一监管路径的双重性展开讨论。
来源:FDA · 药品动态 · news.google.com